These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28831081)

  • 1. EGFR and PDGFRA co-expression and heterodimerization in glioblastoma tumor sphere lines.
    Chakravarty D; Pedraza AM; Cotari J; Liu AH; Punko D; Kokroo A; Huse JT; Altan-Bonnet G; Brennan CW
    Sci Rep; 2017 Aug; 7(1):9043. PubMed ID: 28831081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response.
    Szerlip NJ; Pedraza A; Chakravarty D; Azim M; McGuire J; Fang Y; Ozawa T; Holland EC; Huse JT; Jhanwar S; Leversha MA; Mikkelsen T; Brennan CW
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3041-6. PubMed ID: 22323597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A heat shock protein 90 inhibitor reduces oncoprotein expression and induces cell death in heterogeneous glioblastoma cells with EGFR, PDGFRA, CDK4, and NF1 aberrations.
    Ho KT; Chen PF; Chuang JY; Gean PW; Hsueh YS
    Life Sci; 2022 Jan; 288():120176. PubMed ID: 34848192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct phenotypic differences associated with differential amplification of receptor tyrosine kinase genes at 4q12 in glioblastoma.
    Burford A; Little SE; Jury A; Popov S; Laxton R; Doey L; Al-Sarraj S; Jürgensmeier JM; Jones C
    PLoS One; 2013; 8(8):e71777. PubMed ID: 23990986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme.
    Joensuu H; Puputti M; Sihto H; Tynninen O; Nupponen NN
    J Pathol; 2005 Oct; 207(2):224-31. PubMed ID: 16021678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR signaling in the HGG-02 glioblastoma cell line with an unusual loss of EGFR gene copy.
    Skoda J; Neradil J; Zitterbart K; Sterba J; Veselska R
    Oncol Rep; 2014 Jan; 31(1):480-7. PubMed ID: 24270553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas.
    Puputti M; Tynninen O; Sihto H; Blom T; Mäenpää H; Isola J; Paetau A; Joensuu H; Nupponen NN
    Mol Cancer Res; 2006 Dec; 4(12):927-34. PubMed ID: 17189383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coactivated platelet-derived growth factor receptor {alpha} and epidermal growth factor receptor are potential therapeutic targets in intimal sarcoma.
    Dewaele B; Floris G; Finalet-Ferreiro J; Fletcher CD; Coindre JM; Guillou L; Hogendoorn PC; Wozniak A; Vanspauwen V; Schöffski P; Marynen P; Vandenberghe P; Sciot R; Debiec-Rychter M
    Cancer Res; 2010 Sep; 70(18):7304-14. PubMed ID: 20685895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EPHA2 mediates PDGFA activity and functions together with PDGFRA as prognostic marker and therapeutic target in glioblastoma.
    Gai QJ; Fu Z; He J; Mao M; Yao XX; Qin Y; Lan X; Zhang L; Miao JY; Wang YX; Zhu J; Yang FC; Lu HM; Yan ZX; Chen FL; Shi Y; Ping YF; Cui YH; Zhang X; Liu X; Yao XH; Lv SQ; Bian XW; Wang Y
    Signal Transduct Target Ther; 2022 Feb; 7(1):33. PubMed ID: 35105853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ analysis of integrin and growth factor receptor signaling pathways in human glioblastomas suggests overlapping relationships with focal adhesion kinase activation.
    Riemenschneider MJ; Mueller W; Betensky RA; Mohapatra G; Louis DN
    Am J Pathol; 2005 Nov; 167(5):1379-87. PubMed ID: 16251422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of anti-epidermal growth factor receptor monoclonal antibody C225 against glioblastoma multiforme.
    Eller JL; Longo SL; Hicklin DJ; Canute GW
    Neurosurgery; 2002 Oct; 51(4):1005-13; discussion 1013-4. PubMed ID: 12234411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGFRvIII tumorigenicity requires PDGFRA co-signaling and reveals therapeutic vulnerabilities in glioblastoma.
    Yeo AT; Jun HJ; Appleman VA; Zhang P; Varma H; Sarkaria JN; Charest A
    Oncogene; 2021 Apr; 40(15):2682-2696. PubMed ID: 33707748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-219-5p inhibits receptor tyrosine kinase pathway by targeting EGFR in glioblastoma.
    Rao SA; Arimappamagan A; Pandey P; Santosh V; Hegde AS; Chandramouli BA; Somasundaram K
    PLoS One; 2013; 8(5):e63164. PubMed ID: 23690991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma.
    Longatto-Filho A; Pinheiro C; Martinho O; Moreira MA; Ribeiro LF; Queiroz GS; Schmitt FC; Baltazar F; Reis RM
    BMC Cancer; 2009 Jun; 9():212. PubMed ID: 19563658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C3G downregulation induces the acquisition of a mesenchymal phenotype that enhances aggressiveness of glioblastoma cells.
    Manzano S; Gutierrez-Uzquiza A; Bragado P; Sequera C; Herranz Ó; Rodrigo-Faus M; Jauregui P; Morgner S; Rubio I; Guerrero C; Porras A
    Cell Death Dis; 2021 Apr; 12(4):348. PubMed ID: 33824275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparan Sulfate Synthesized by
    Ohkawa Y; Wade A; Lindberg OR; Chen KY; Tran VM; Brown SJ; Kumar A; Kalita M; James CD; Phillips JJ
    Mol Cancer Res; 2021 Jan; 19(1):150-161. PubMed ID: 33028660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial growth factor receptor expression influences 5-ALA induced glioblastoma fluorescence.
    Fontana AO; Piffaretti D; Marchi F; Burgio F; Faia-Torres AB; Paganetti P; Pinton S; Pieles U; Reinert M
    J Neurooncol; 2017 Jul; 133(3):497-507. PubMed ID: 28500562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas.
    Ozawa T; Brennan CW; Wang L; Squatrito M; Sasayama T; Nakada M; Huse JT; Pedraza A; Utsuki S; Yasui Y; Tandon A; Fomchenko EI; Oka H; Levine RL; Fujii K; Ladanyi M; Holland EC
    Genes Dev; 2010 Oct; 24(19):2205-18. PubMed ID: 20889717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme.
    Giannini C; Sarkaria JN; Saito A; Uhm JH; Galanis E; Carlson BL; Schroeder MA; James CD
    Neuro Oncol; 2005 Apr; 7(2):164-76. PubMed ID: 15831234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ErbB Receptors and Cancer.
    Wang Z
    Methods Mol Biol; 2017; 1652():3-35. PubMed ID: 28791631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.